Question 1

What is an SFDA MDMA, and why is it mandatory for medical devices in Saudi Arabia?

Accepted Answer

The Medical Device Marketing Authorization (MDMA) is the official regulatory approval issued by the Saudi Food and Drug Authority (SFDA). It certifies that a medical device or in-vitro diagnostic (IVD) conforms to Saudi technical, safety, and performance standards. No medical device can clear customs or be marketed commercially in the Kingdom of Saudi Arabia without an active MDMA certificate or MDNR listing.

Executive Regulatory Advisory

Have a Specific Device, Chemical, or Dossier Question?

Our Senior Regulatory Directorate will review your device classification, predicate history, and SFDA pathway in an executive session.

Submit Detailed Dossier

Question 2

Why should a foreign manufacturer unbundle their Authorized Representative from their commercial distributor?

Accepted Answer

Under SFDA regulations, holding an Authorized Representative (AR) license gives the holder legal guardianship over the product's marketing authorizations. If a commercial distributor acts as your AR, they effectively own the market clearance. If performance issues arise or you wish to onboard secondary distributors, transferring the license can trigger protracted legal negotiations and commercial disruptions. Appointing Muhrat Al Marasim as an independent, neutral AR gives you 100% license ownership, enabling you to appoint, change, or expand multiple commercial distributors freely.

Question 3

What are the typical review timelines for SFDA medical device submissions?

Accepted Answer

Timelines depend on risk classification and submission completeness: Class I devices listed under MDNR take 2 to 4 weeks. Class IIa and IIb moderate-risk devices evaluated under the MDMA pathway take approximately 6 to 12 weeks. Class III high-risk implantables and novel technologies take 14 to 24 weeks. Muhrat Al Marasim's pre-submission screening pre-empts deficiency notices, cutting average review cycles by up to 40%.

Question 4

Is ISO 13485:2016 certification mandatory for medical device importers and manufacturers in Saudi Arabia?

Accepted Answer

Yes. The SFDA mandates that both legal manufacturers and local establishment license holders (MDEL) maintain a certified Quality Management System complying with ISO 13485:2016. Foreign manufacturers must submit current ISO 13485 certificates issued by accredited notified bodies or auditing organizations recognized under the MDSAP (Medical Device Single Audit Program).

Question 5

What are the Saudi-specific labeling and language requirements?

Accepted Answer

The SFDA strictly enforces bilingual or Arabic labeling requirements depending on product use. For professional-use medical devices, Instructions for Use (IFU) and technical manuals may be in English, but outer packaging, critical warnings, and user-facing labels must incorporate Arabic text. For consumer/patient-use healthcare devices, all outer packaging, labeling, and patient leaflets must be fully bilingual in English and Arabic. Additionally, barcodes must comply with GS1 / UDI-DI standards registered in the Saudi UDI database.

Question 6

How does the SFDA handle pharmaceutical eCTD submissions?

Accepted Answer

The SFDA requires all human drug dossiers to be submitted in electronic Common Technical Document (eCTD) format utilizing GCC Module 1 v3.0 specifications. Modules 2 through 5 follow standard ICH guidelines. Foreign manufacturers must also undergo site GMP clearance, either through mutual recognition or an on-site / remote audit conducted by SFDA inspectors.

Question 7

What responsibilities does Muhrat Al Marasim undertake as a licensed KSA Authorized Representative?

Accepted Answer

As your licensed Saudi AR, Muhrat Al Marasim acts as your official legal and regulatory liaison to the SFDA. Responsibilities include: dossier compilation and GHAD portal submission, obtaining import clearance endorsements, post-market vigilance management (monitoring 24/7 incident hotlines, reporting adverse events, coordinating field safety notices), maintaining bilingual technical files, and managing annual renewals and variations.

Question 8

What is the validity period of an SFDA MDMA certificate?

Accepted Answer

An SFDA MDMA certificate is typically issued for a validity period of 3 years (or tied to the expiry date of the manufacturer's CE mark / foreign reference authorization). Renewal applications should be initiated 90 to 120 days prior to expiration through your appointed Authorized Representative to prevent customs clearance interruptions.

Frequently asked questions.

Have a Specific Device, Chemical, or Dossier Question?